Fragment-based Drug Discovery (FBDD) is a rapidly developing alternative to screening drug-like compounds.It starts with synthesizing and then screening fragment-based libraries composed of compounds that have lower molecular weight and lower molecular complexity than suggested by Lipinski Rule of 5.The process of synthesis is guided by a heuristic rule,which is called Rule of 3.